Venlo, The Netherlands – QIAGEN N.V. (”NASDAQ: QGEN; Frankfurt Prime Standard: QIA”) announced on 29 March 2016 that QIAGEN N.V had decided to make a conditional, voluntary public tender offer for the shares of Exiqon A/S in which the shareholders of Exiqon are offered a cash amount of DKK 18 for each share they hold in Exiqon A/S (the “Offer”).

The Offer for the Exiqon shares represents a premium of 41.7 per cent to the closing price per Exiqon Share on Nasdaq Copenhagen A/S (“Nasdaq Copenhagen”) on March 29, 2016 and a premium of 52.9 per cent to the average closing price on NASDAQ Copenhagen in the three months up to and including 29 March 2016.

In accordance with section 4 of the Danish Executive Order no. 562 of 2 June 2014 regarding takeover bids, etc., QIAGEN N.V. has today published an offering document with a more specific description of the terms and conditions of the Offer.

The Offer is made neither directly nor indirectly in any jurisdiction where this would constitute a violation of the legislation within the jurisdiction in question. This announcement and other documents regarding the Offer, including the offering document, must not be sent, forwarded or distributed in any other way within a jurisdiction where this would or could constitute a violation of legislation within said jurisdiction, including in particular in Canada, Japan, Australia or South Africa.

This announcement does not constitute an offer or invitation to sell or buy shares in Exiqon A/S. The Offer is made solely on the basis of the offer document prepared and published by QIAGEN N.V., which contains the complete terms and conditions of the Offer. Shareholders in Exiqon A/S are recommended to read the offer document and any associated documents, as these will contain significant information regarding the Offer.